Luca Hensen

Luca Hensen

Auto-generated profile, based on publicly available information

Luca Hensen

University of Melbourne

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JHJennifer R. Habel
Jennifer R. Habel
TNThi Hoang Oanh Nguyen
Thi Hoang Oanh Nguyen
Carolien Emma van de SandtCarolien Emma van de Sandt
Carolien Emma van de Sandt
JJJennifer Juno
Jennifer Juno
PCPriyanka Chaurasia
Priyanka Chaurasia
KKKatherine Kedzierska
Katherine Kedzierska
Significance: As the recall of CD8 + T cell memory promotes rapid recovery in, for example, influenza, we investigated circulating SARS-CoV-2−specific CD8 + T cells from COVID-19 patients. For two HLA-A*02:01 SARS-CoV-2−specific CD8 + T cell epitopes, we found that, while ex vivo frequencies of responding T cells were approximately fivefold higher than for pre−COVID-19 samples, they were ∼10-fold lower than for influenza or EBV-specific memory CD8 + T cells. Additionally, SARS-CoV-2−specific CD8 + T cells recovered from convalescent COVID-19 patients had an atypically high prevalence of stem cell memory, central memory, and naïve phenotypes. Might this unexpectedly low prevalence of classical effector memory T cells be a negative consequence of the infectious process that could be avoided by prior priming with an appropriately constituted vaccine?

1 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKevin J. Selva
Kevin J. Selva
Carolien Emma van de SandtCarolien Emma van de Sandt
Carolien Emma van de Sandt
MLMelissa M. Lemke
Melissa M. Lemke
CLChristina Y. Lee
Christina Y. Lee
SSSuzanne K. Shoffner
Suzanne K. Shoffner
ACAmy W. Chung
Amy W. Chung
The hallmarks of COVID-19 are higher pathogenicity and mortality in the elderly compared to children. Examining baseline SARS-CoV-2 cross-reactive immunological responses, induced by circulating human coronaviruses (hCoVs), is needed to understand such divergent clinical outcomes. Here we show analysis of coronavirus antibody responses of pre-pandemic healthy children (n = 89), adults (n = 98), elderly (n = 57), and COVID-19 patients (n = 50) by systems serology. Moderate levels of cross-reactive, but non-neutralizing, SARS-CoV-2 antibodies are detected in pre-pandemic healthy individuals. SARS-CoV-2 antigen-specific Fcγ receptor binding accurately distinguishes COVID-19 patients from healthy individuals, suggesting that SARS-CoV-2 infection induces qualitative changes to antibody Fc, enhancing Fcγ receptor engagement. Higher cross-reactive SARS-CoV-2 IgA and IgG are observed in healthy elderly, while healthy children display elevated SARS-CoV-2 IgM, suggesting that children have fewer hCoV exposures, resulting in less-experienced but more polyreactive humoral immunity. Age-dependent analysis of COVID-19 patients, confirms elevated class-switched antibodies in elderly, while children have stronger Fc responses which we demonstrate are functionally different. These insights will inform COVID-19 vaccination strategies, improved serological diagnostics and therapeutics.

28 July 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
RFRyan J. Farr
Ryan J. Farr
CRChristina L. Rootes
Christina L. Rootes
LRLouise C. Rowntree
Louise C. Rowntree
TNThi Hoang Oanh Nguyen
Thi Hoang Oanh Nguyen
LHLuca Hensen
Luca Hensen
CSCameron R. Stewart
Cameron R. Stewart
The host response to SARS-CoV-2 infection provide insights into both viral pathogenesis and patient management. The host-encoded microRNA (miRNA) response to SARS-CoV-2 infection, however, remains poorly defined. Here we profiled circulating miRNAs from ten COVID-19 patients sampled longitudinally and ten age and gender matched healthy donors. We observed 55 miRNAs that were altered in COVID-19 patients during early-stage disease, with the inflammatory miR-31-5p the most strongly upregulated. Supervised machine learning analysis revealed that a three-miRNA signature (miR-423-5p, miR-23a-3p and miR-195-5p) independently classified COVID-19 cases with an accuracy of 99.9%. In a ferret COVID-19 model, the three-miRNA signature again detected SARS-CoV-2 infection with 99.7% accuracy, and distinguished SARS-CoV-2 infection from influenza A (H1N1) infection and healthy controls with 95% accuracy. Distinct miRNA profiles were also observed in COVID-19 patients requiring oxygenation. This study demonstrates that SARS-CoV-2 infection induces a robust host miRNA response that could improve COVID-19 detection and patient management.

1 May 2021 in Immunity
Verified
Journal Article
Closed access
TNThi Hoang Oanh Nguyen
Thi Hoang Oanh Nguyen
LRLouise C. Rowntree
Louise C. Rowntree
JPJan Petersen
Jan Petersen
BCBrendon Y. Chua
Brendon Y. Chua
LHLuca Hensen
Luca Hensen
KKKatherine Kedzierska
Katherine Kedzierska

17 February 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MAMaria Auladell
Maria Auladell
HPHoang Vu Mai Phuong
Hoang Vu Mai Phuong
LMLe Thi Quynh Mai
Le Thi Quynh Mai
YTYeu-Yang Tseng
Yeu-Yang Tseng
LCLouise Carolan
Louise Carolan
AFAnnette Fox
Annette Fox

2 July 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MAMaria Auladell
Maria Auladell
XJXiaoxiao Jia
Xiaoxiao Jia
LHLuca Hensen
Luca Hensen
BCBrendon Chua
Brendon Chua
AFAnnette Fox
Annette Fox
KKKatherine Kedzierska
Katherine Kedzierska
Persistent and durable immunological memory forms the basis of any successful vaccination protocol. Generation of pre-existing memory B cell and T cell pools is thus the key for maintaining protective immunity to seasonal, pandemic and avian influenza viruses. Long-lived antibody secreting cells (ASCs) are responsible for maintaining antibody levels in peripheral blood. Generated with CD4+ T help after naïve B cell precursors encounter their cognate antigen, the linked processes of differentiation (including Ig class switching) and proliferation also give rise to memory B cells, which then can change rapidly to ASC status after subsequent influenza encounters. Given that influenza viruses evolve rapidly as a consequence of antibody-driven mutational change (antigenic drift), the current influenza vaccines need to be reformulated frequently and annual vaccination is recommended. Without that process of regular renewal, they provide little protection against “drifted” (particularly H3N2) variants and are mainly ineffective when a novel pandemic (2009 A/H1N1 “swine” flu) strain suddenly emerges. Such limitation of antibody-mediated protection might be circumvented, at least in part, by adding a novel vaccine component that promotes cross-reactive CD8+ T cells specific for conserved viral peptides, presented by widely distributed HLA types. Such “memory” cytotoxic T lymphocytes (CTLs) can rapidly be recalled to CTL effector status. Here, we review how B cells and follicular T cells are elicited following influenza vaccination and how they survive into a long-term memory. We describe how CD8+ CTL memory is established following influenza virus infection, and how a robust CTL recall response can lead to more rapid virus elimination by destroying virus-infected cells, and recovery. Exploiting long-term, cross-reactive CTL against the continuously evolving and unpredictable influenza viruses provides a possible mechanism for preventing a disastrous pandemic comparable to the 1918-1919 H1N1 “Spanish flu,” which killed more than 50 million people worldwide.